chondrocyte-alginate gel suspension
Phase 3UNKNOWN 0 watching 0 views this week📈 Rising
69
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Vesicoureteral Reflux
Conditions
Vesicoureteral Reflux
Trial Timeline
May 1, 1999 → —
NCT ID
NCT00004487About chondrocyte-alginate gel suspension
chondrocyte-alginate gel suspension is a phase 3 stage product being developed by Curis for Vesicoureteral Reflux. The current trial status is unknown. This product is registered under clinical trial identifier NCT00004487. Target conditions include Vesicoureteral Reflux.
Hype Score Breakdown
Clinical
27
Activity
18
Company
2
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00004487 | Phase 3 | UNKNOWN |